Pre-IPO Review
Pre-IPO ReviewAggregating reviews, news, and community signal on pre-IPO companies

Insitro

🧬 BCI/Biotech

Machine-learning-driven drug discovery in metabolic, neuro and oncology disease

MLDrug DiscoveryPhenotype
$2.57B
Latest valuation
👀 0💬 0
Valuation
$2.57B
Total Funding
$628.63M
Founded
2018
HQ
South San Francisco, CA
📊 View full data on Sacra →

📰 Company News

Daphne Koller Calls for Closer Academia-Industry Collaboration in AI
via Yahoo·2026-08-08↗
AI Revolutionizes ALS Drug Development with Major Investments
via Target ALS·2026-06-22↗
Insitro Raises $243 Million to Transform Drug Discovery
via StartupHub.ai·2026-05-17↗

🤝 Related Companies

Colossal Biosciences
$10.2B
👀 0💬 0
Neuralink
$9.65B
👀 0💬 1
Isomorphic Labs
$5B
👀 0💬 0
Altos Labs
$3B
👀 0💬 0
Generate Biomedicines
$2B
👀 0💬 0
Xaira Therapeutics
$2B
👀 0💬 0

📰 Articles

No articles yet. Be the first to share one.

Reviews (0)

🔥 Most Helpful🕐 Newest
No reviews yet. Be the first.